Why it matters
PepsiCo subsidiary Wimm-Bill-Dann JSC manufactures and sells baby food in Russia, Ukraine and Central Asia. Through our baby foods portfolio, we aim to promote safe and adequate nutrition for infants and young children. We understand that our consumers and other stakeholders expect our marketing of these products not to interfere with or discourage optimal breastfeeding. We are committed to ensuring that we market these products responsibly and support breastfeeding as the best type of nutrition in the first six months of life.
To the World:
Optimal nutrition in the first 1,000 days of a child's life is essential to ensure proper development and long-term health. The World Health Organization recommends infants be exclusively breastfed during their first six months of life and continue to be breastfed for up to two years and beyond. Commercial breast-milk substitutes (BMS) can provide infants with needed nutrition when a safe alternative to breast-milk is required, and complementary foods provide needed energy and essential nutrients for young children as they grow.
PepsiCo understands that it is vital to communicate responsibly about all our products, including breast-milk substitutes (BMS). We support:
- The principles of the International Code of Marketing of Breast-milk Substitutes and subsequent resolutions (the Code)
- The World Health Organization’s recommendation of exclusive breastfeeding for the first six months of an infant’s life, and continued breastfeeding for up to two years and beyond
- The adoption of science-based laws and regulations that promote optimal feeding practices in the interest of maternal and infant health and nutrition, including policies that codify the Code in national laws and regulations
Baby foods comprise a small part of our overall operations, accounting for less than 1% of global net revenue in 2021. Within that business, approximately 2% of net revenue derives from infant formula and follow-on formula.
Wimm-Bill-Dann’s Policy on the Marketing of Breast-Milk Substitutes sets clear standards for products in this category. The policy guides how the company communicates about infant formulas and complementary foods for infants to the general public and healthcare professionals. The policy is binding and applies in all countries where the company sells baby food products, even where local laws and regulations are absent or less stringent. This policy:
- Prohibits the marketing of infant formulas for infants under 12 months to the general public;
- Prohibits bonuses, benefits, or quotas tied to the sale of infant formula;
- Specifies the labeling required on infant formulas and complementary foods for infants under 12 months, and related informational materials; and
- Places restrictions on company engagement with health systems and healthcare professionals.
Across the portfolio, PepsiCo ensures our products meet the highest standards for food quality and safety, and we follow Codex Alimentarius Commission product formulation recommendations for infant formula and complementary foods unless they contradict relevant local laws and regulations or are inappropriate due to factors such as climate, geography or technological barriers. For more on how we maintain high safety and quality standards, see Product Safety and Quality.
PepsiCo was one of 17 companies to respond to the BMS Call to Action put forth in 2020 by a group of civil society organizations and United Nations agencies. In our response, PepsiCo affirmed our commitment to the principles of the Code and increased transparency around our BMS marketing policies.
As part of our response to the BMS Call to Action, we have committed to:
- Exploring ways to execute independent compliance audits of our BMS policy; and
- Continuing to engage with key stakeholders such as the Access to Nutrition Initiative around our BMS portfolio, demonstrating transparency around how we market breast-milk substitutes.
November 22, 2022